AXVIX Performance — Acclivity Small Cap Value Fund, Class I
Data updated: 2026-09-08
AXVIX returned +17.76% year to date and +30.98% over one year to Jun 2026. Annualised returns are +14.52% over 3 years and +10.14% over 5 years. Against its US Small Value category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $150, against $153 for the category, and to $131 over one year, against $131. Volatility over the past three years was 18.79% a year. In the 12 months to Jun 2026 the fund lost a net $2.9M, and assets reached $35.11M.
AXVIX Growth of $100
What $100 invested in Acclivity Small Cap Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Value category average over the same months.
| Period | AXVIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $131 | $131 |
| 3 years (Jul 2023 – Jun 2026) | $150 | $153 |
| 5 years (Jul 2021 – Jun 2026) | $162 | $149 |
| Since data start (Jan 2020 – Jun 2026) | $229 | $199 |
AXVIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +17.76% |
| 1 year | +30.98% |
| 3 years (annualised) | +14.52% |
| 5 years (annualised) | +10.14% |
AXVIX Annual Returns
Calendar-year total returns of Acclivity Small Cap Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +17.76% |
| 2025 | +5.14% |
| 2024 | +5.70% |
| 2023 | +22.63% |
| 2022 | −4.38% |
| 2021 | +38.59% |
| 2020 | +7.51% |
AXVIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.3% | +2.8% | −2.7% | +7.3% | −0.6% | +4.9% | — | — | — | — | — | — |
| 2025 | +3.0% | −5.7% | −5.9% | −5.9% | +5.2% | +4.6% | +0.5% | +8.6% | 0.0% | −2.5% | +3.8% | +0.7% |
| 2024 | −3.1% | +1.9% | +5.0% | −6.4% | +4.5% | −2.9% | +10.2% | −2.9% | −0.1% | −1.8% | +10.4% | −7.2% |
| 2023 | +9.8% | −1.2% | −7.0% | −2.5% | −1.6% | +10.4% | +7.1% | −3.0% | −4.3% | −5.3% | +8.7% | +12.2% |
| 2022 | −2.9% | +1.3% | +0.5% | −5.2% | +3.4% | −10.0% | +10.1% | −2.7% | −10.1% | +14.6% | +5.2% | −5.5% |
| 2021 | +5.1% | +10.6% | +7.4% | +2.4% | +4.9% | −2.1% | −2.1% | +2.6% | −1.7% | +3.4% | −2.1% | +5.7% |
| 2020 | −6.1% | −9.1% | −28.3% | +17.2% | +4.6% | +3.1% | +3.4% | +5.5% | −4.7% | +5.2% | +18.5% | +7.2% |
AXVIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 18.79%
- 3-year Sharpe ratio: 0.53 (vs 4.5% risk-free rate)
- Best month: +12.18% (Dec 2023)
- Worst month: −7.22% (Dec 2024)
AXVIX Fund Flows
Monthly money in and out of Acclivity Small Cap Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$2.9M
- 12-month gross sales (incl. reinvestments): $8.3M
- Sales ÷ redemptions: 0.74×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $464K | $869K | −$405K |
| May 2026 | $502K | $477K | $25K |
| Apr 2026 | $2.1M | $328K | $1.7M |
| Mar 2026 | $337K | $1.1M | −$729K |
| Feb 2026 | $1.0M | $586K | $428K |
| Jan 2026 | $291K | $522K | −$231K |
| Dec 2025 | $1.6M | $4.2M | −$2.6M |
| Nov 2025 | $328K | $585K | −$256K |
| Oct 2025 | $228K | $464K | −$236K |
| Sep 2025 | $195K | $602K | −$406K |
| Aug 2025 | $1.1M | $1.2M | −$163K |
| Jul 2025 | $308K | $317K | −$9K |
AXVIX Assets Under Management
Net assets of Acclivity Small Cap Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $35.11M |
| 2026-03-31 | $30.07M |
| 2025-12-31 | $29.13M |
| 2025-09-30 | $32.89M |
| 2025-06-30 | $30.71M |
| 2025-03-31 | $32.46M |
| 2024-12-31 | $38.05M |
| 2024-09-30 | $36.29M |
| 2024-06-30 | $34.66M |
| 2024-03-31 | $32.74M |
| 2023-12-31 | $27.91M |
| 2023-09-30 | $20.69M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.